This subproject is one of many research subprojects utilizing theresources provided by a Center grant funded by NIH/NCRR. The subproject andinvestigator (PI) may have received primary funding from another NIH source,and thus could be represented in other CRISP entries. The institution listed isfor the Center, which is not necessarily the institution for the investigator.
SPECIFIC AIMS :
Specific Aim #1 To evaluate the effect of treatment with oral statin therapy on sympathetic nerve activation in subjects with heart failure of non-ischemic etiologySpecific Aim#2 To evaluate the effect of treatment with oral statin therapy on changes in cardiac structure and function in subjects with heart failure of non-ischemic etiology Secondary objectives:To evaluate the effects of statin therapy on symptoms, quality of life, arrhythmias, heart failure biomarkers (B-type natriuretic peptide, cardiac troponin I, high sensitivity C-reactive protein, and additional proteomic analysis), and a clinical composite score in patients with heart failure.
Showing the most recent 10 out of 1085 publications